Herbalife Ltd. (HLF)
NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Wholesale trade · CIK 1180262 · fiscal year ends in Dec
Closing price $12.92 on 29 Oct 2026; 52-week range $7.75 to $19.96.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $5.2B
- Revenue growth
- 5.5%
- Net income, last twelve months
- $164.2M
- Earnings per share
- $1.55
- Gross margin
- 77.7%
- Operating margin
- 9.5%
- Net margin
- 3.2%
- Free cash flow
- $322.3M
- Market value
- $1.4B
- Price to earnings
- 8.3x
- Cash
- $370.5M
- Debt
- $2.0B
- Shares outstanding
- 104.8M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $5.0B | $481.0M | $228.3M | $2.20 | $252.9M | 10-K filed 18 Feb 2026 |
| FY2024 | 31 Dec 2024 | $5.0B | $385.9M | $254.3M | $2.50 | $163.4M | 10-K filed 19 Feb 2025 |
| FY2023 | 31 Dec 2023 | $5.1B | $356.4M | $142.2M | $1.42 | $222.5M | 10-K filed 14 Feb 2024 |
| FY2022 | 31 Dec 2022 | $5.2B | $545.2M | $321.3M | $3.23 | $196.1M | 10-K filed 14 Feb 2023 |
| FY2021 | 31 Dec 2021 | $5.8B | $734.1M | $447.2M | $4.13 | $308.9M | 10-K filed 23 Feb 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $1.3B | -$26.3M | -$0.25 |
| Q1 FY2026 | 31 Mar 2026 | $1.3B | $61.9M | $0.57 |
| Q4 FY2025 | 31 Dec 2025 | $1.3B | $85.4M | $0.81 |
| Q3 FY2025 | 30 Sep 2025 | $1.3B | $43.2M | $0.42 |
| Q2 FY2025 | 30 Jun 2025 | $1.3B | $49.3M | $0.48 |
| Q1 FY2025 | 31 Mar 2025 | $1.2B | $50.4M | $0.49 |
| Q4 FY2024 | 31 Dec 2024 | $1.2B | $177.9M | $1.74 |
| Q3 FY2024 | 30 Sep 2024 | $1.2B | $47.4M | $0.46 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By product, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Weight Management | $2.7B | 54.5% |
| Targeted Nutrition | $1.5B | 30.0% |
| Energy, Sports, and Fitness | $617.1M | 12.3% |
| Outer Nutrition | $85.0M | 1.7% |
| Literature, Promotional and Other | $79.1M | 1.6% |
Company events
The newest 8-K filings of 267 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 31 Aug 2026 | 8-K | Leadership change | 5.02 |
| 5 Aug 2026 | 8-K | Results, Leadership change, Investor update | 2.02, 5.02, 7.01, 9.01 |
| 6 May 2026 | 8-K | Results, Shareholder vote, Investor update | 2.02, 5.07, 7.01, 9.01 |
| 1 May 2026 | 8-K | Material agreement, New debt, Debt accelerated, Other events | 1.01, 2.03, 2.04, 8.01, 9.01 |
| 16 Apr 2026 | 8-K | Other events | 8.01, 9.01 |
| 14 Apr 2026 | 8-K | Results, Other events | 2.02, 8.01, 9.01 |
| 18 Feb 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 5 Nov 2025 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 6 Aug 2025 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 16 Jun 2025 | 8-K | Other events | 8.01 |
| 30 Apr 2025 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 25 Apr 2025 | 8-K | Shareholder vote | 5.07 |
Every filing
The newest filings with the SEC of 557 held.
| Filed | Form | Period |
|---|---|---|
| 31 Aug 2026 | 8-K | 25 Aug 2026 |
| 5 Aug 2026 | 8-K | 30 Jul 2026 |
| 5 Aug 2026 | 10-Q | 30 Jun 2026 |
| 6 May 2026 | 8-K | 30 Apr 2026 |
| 6 May 2026 | 10-Q | 31 Mar 2026 |
| 1 May 2026 | 8-K | 29 Apr 2026 |
| 16 Apr 2026 | 8-K | 15 Apr 2026 |
| 14 Apr 2026 | 8-K | 14 Apr 2026 |
| 17 Mar 2026 | ARS | 31 Dec 2025 |
| 17 Mar 2026 | DEFA14A | – |
| 17 Mar 2026 | DEF 14A | 30 Apr 2026 |
| 18 Feb 2026 | 8-K | 18 Feb 2026 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 4 Jun 2026 | L'Helias Sophie, Director | Purchase | 1,200 | $11.31 | $13.6K | 79,882 | 4 Jun 2026 |
| 19 May 2026 | Hicks Troy, Chief Operating Officer | Sale outside a trading plan | 10,000 | $12.32 | $123.2K | 9,706 | 20 May 2026 |
| 18 May 2026 | Hicks Troy, Chief Operating Officer | Sale outside a trading plan | 38,377 | $12.93 | $496.3K | 9,062 | 20 May 2026 |
| 12 May 2026 | Lamberti Frank, Chief Commercial Officer | Sale outside a trading plan | 134,982 | $13.50 | $1.8M | 36,624 | 12 May 2026 |
| 11 May 2026 | Lamberti Frank, Chief Commercial Officer | Sale outside a trading plan | 7,937 | $13.86 | $110.0K | 171,606 | 12 May 2026 |
| 1 Dec 2025 | L'Helias Sophie, Director | Purchase | 800 | $12.70 | $10.2K | 66,803 | 1 Dec 2025 |
| 26 Nov 2025 | L'Helias Sophie, Director | Purchase | 400 | $13.22 | $5.3K | 66,003 | 1 Dec 2025 |
| 18 Nov 2025 | Cloud Lynda, Director | Purchase | 17,000 | $8.97 | $152.5K | 38,857 | 20 Nov 2025 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 19 May 2026 | Hicks Troy, Officer | 10,000 | $123.2K | 19 May 2026 |
| 18 May 2026 | Hicks Troy, Officer | 38,377 | $496.3K | 18 May 2026 |
| 12 May 2026 | Lamberti Frank, Officer | 134,982 | $1.8M | 12 May 2026 |
| 11 May 2026 | Lamberti Frank, Officer | 7,937 | $110.0K | 11 May 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 13 Aug 2026 | Renaissance Technologies LLC | 13G amended | 4.79% | 5.0M |
| 6 Aug 2026 | FMR LLC | 13G amended | 2.6% | 2.7M |
| 15 May 2026 | Nantahala Capital Management, LLC | 13G amended | 6.72% | 7.0M |
| 6 May 2026 | FMR LLC | 13G | 5.3% | 5.4M |
| 29 Apr 2026 | Vanguard Portfolio Management | 13G | 6.12% | 6.3M |
| 28 Apr 2026 | Vanguard Capital Management | 13G | 5% | 5.2M |
| 26 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
| 13 Feb 2026 | Nantahala Capital Management, LLC | 13G amended | 8.4% | 8.7M |
| 12 Feb 2026 | Renaissance Technologies LLC | 13G amended | 5.44% | 5.6M |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 8.0M | -1.98% | 5.55 |
| 30 Sep 2026 | 8.1M | -9.66% | 5.61 |
| 15 Sep 2026 | 9.0M | +3.39% | 5.17 |
| 31 Aug 2026 | 8.7M | -6.26% | 5.25 |
| 14 Aug 2026 | 9.3M | +2.54% | 5.05 |
| 31 Jul 2026 | 9.1M | -2.62% | 7.9 |
| 15 Jul 2026 | 9.3M | +8.22% | 5.62 |
| 30 Jun 2026 | 8.6M | +8.5% | 4.18 |
Funds that hold it
From each fund's latest Form 13F.
279 funds held it at 30 Jun 2026: 123 added and 70 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| Baupost Group LLC | 9,259,844 | $121.8M | 0 |
| BlackRock, Inc. | 8,371,046 | $110.1M | +549,342 |
| Route One Investment Company, L.P. | 8,348,800 | $109.8M | +121,500 |
| Vanguard Portfolio Management LLC | 6,192,277 | $81.4M | +106,192 |
| Renaissance Technologies LLC | 5,024,668 | $66.1M | -475,300 |
| Vanguard Capital Management LLC | 4,411,900 | $58.0M | -2,357 |
| Geode Capital Management, LLC | 3,465,068 | $45.6M | +836,631 |
| Solel Partners LP | 2,848,115 | $37.5M | +987,500 |
| LSV Asset Management | 2,622,894 | $34.5M | -3,200 |
| State Street Corp. | 2,545,868 | $33.5M | +124,047 |
Peers
Companies in the same industry.
- McKesson Corp. (MCK): revenue $411.0B, market value $114.5B
- Cencora, Inc. (COR): revenue $332.8B, market value $63.1B
- Cardinal Health Inc. (CAH): revenue $254.2B, market value $58.4B